Related Experiment Video

Updated: Jun 18, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
12:12

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes

Published on: June 16, 2011

The role of perforin and granzymes in diabetes

H E Thomas1, J A Trapani, T W H Kay

  • 1Department of Immunology and Diabetes, St Vincent's Institute, 41 Victoria Parade, Fitzroy, Melbourne 3065, Australia. hthomas@svi.edu.au

Cell Death and Differentiation
|November 21, 2009
PubMed

Insights

Type 1 diabetes involves CD8(+) T cells destroying pancreatic beta-cells. Blocking the perforin/granzyme pathway shows promise for treating type 1 diabetes and preventing islet graft rejection.

Area of Science:

  • Immunology
  • Endocrinology
  • Cell Biology

Background:

  • Type 1 diabetes (T1D) arises from autoimmune destruction of pancreatic beta-cells.
  • CD8(+) T cells are key effectors, utilizing perforin and granzymes for beta-cell lysis.
  • The perforin/granzyme pathway is implicated in both T1D pathogenesis and allogeneic islet graft rejection.

Purpose of the Study:

  • To investigate the role of the perforin/granzyme pathway in beta-cell destruction in T1D.
  • To evaluate the therapeutic potential of blocking this pathway for T1D and islet transplantation.
  • To explore the broader role of granzymes in diabetes-related inflammation.

Main Methods:

  • In vitro studies using cytotoxic T cells and beta-cells.
  • In vivo studies utilizing the non-obese diabetic (NOD) mouse model.
  • Analysis of disease incidence in perforin-deficient NOD mice.

Main Results:

  • Diabetogenic cytotoxic T cells kill beta-cells via the perforin/granzyme pathway in vitro.
  • Perforin deficiency significantly reduces diabetes incidence in NOD mice, confirming its in vivo role.
  • Perforin and granzyme B are crucial for allogeneic islet destruction.

Conclusions:

  • The perforin/granzyme pathway is a dominant mechanism in T1D beta-cell destruction and islet graft rejection.
  • Targeting this pathway offers a potential therapeutic strategy for T1D and transplantation.
  • Granzymes' emerging role in inflammation warrants further investigation in both T1D and T2D.

More Related Videos

A Colorimetric Assay that Specifically Measures Granzyme B Proteolytic Activity: Hydrolysis of Boc-Ala-Ala-Asp-S-Bzl05:20

A Colorimetric Assay that Specifically Measures Granzyme B Proteolytic Activity: Hydrolysis of Boc-Ala-Ala-Asp-S-Bzl

Published on: November 28, 2014

Isolated Pancreatic Islet Treatment and Apoptosis Measurement09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...